Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | 2 | -5.47 | 319.6967 | 0.075 | 0.86936 | 0.30949 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 1 | -5.30 | 298.2392 | 0.073 | 0.94086 | 0.48387 | |||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 7.5 | ng/ml | 2 | -5.69 | 426.8136 | 0.208 | 0.91182 | 0.36673 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | 1 | -5.47 | 338.7050 | 0.034 | 0.89448 | 0.31894 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 2 | -5.39 | 331.3306 | 0.083 | 0.86694 | 0.49064 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 5 | -6.05 | 472.6445 | 0.683 | 0.94218 | 0.72805 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 5.0 | ng/ml | 1 | -5.56 | 416.4737 | 0.358 | 0.94737 | 0.58947 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 7.5 | ng/ml | 1 | -5.38 | 333.0821 | 0.012 | 0.94807 | 0.44891 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 250.0 | ng/ml | 1 | -4.31 | 66.9521 | 0.000 | 0.96986 | 0.90411 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 500.0 | ng/ml | 2 | -4.31 | 71.7160 | 0.000 | 0.97284 | 0.94815 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 2 | -4.93 | 186.2624 | 0.010 | 0.90759 | 0.68812 | |||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 1 | -6.20 | 481.7639 | 0.801 | 0.96817 | 0.78780 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 3 | -6.35 | 445.1084 | 0.889 | 0.98103 | 0.88889 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 4 | -6.21 | 485.6552 | 0.814 | 0.97069 | 0.80517 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 1.0 | ng/ml | 1 | -6.43 | 491.0887 | 1.000 | 0.99194 | 0.96774 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 1.0 | ng/ml | 2 | -6.32 | 468.5230 | 0.965 | 0.99344 | 0.91028 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 5.0 | ng/ml | 2 | -5.53 | 404.8037 | 0.065 | 0.83770 | 0.38743 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 5.0 | ng/ml | 3 | -5.79 | 469.2892 | 0.407 | 0.88235 | 0.52941 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 50.0 | ng/ml | 1 | -4.84 | 188.4868 | 0.000 | 1.00000 | 0.89474 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 50.0 | ng/ml | 2 | -4.76 | 163.3246 | 0.000 | 0.99474 | 0.97544 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 250.0 | ng/ml | 2 | -4.37 | 81.7724 | 0.002 | 0.99067 | 0.94403 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | TNF10 | 500.0 | ng/ml | 1 | -4.25 | 57.6070 | 0.002 | 0.97623 | 0.83360 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 1 | -4.70 | 139.7368 | 0.011 | 0.92026 | 0.78469 | |||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 3 | -5.87 | 409.3750 | 0.568 | 0.88750 | 0.68250 | |||
HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 2 | -5.36 | 315.9300 | 0.077 | 0.87923 | 0.49275 |